A Tale of Two Regulatory Philosophies
When you buy sunscreen in Paris, Berlin, or Barcelona, you have access to advanced UV filters that simply don't exist on American shelves. The European Union has approved 30 UV filters for sun protection. The FDA? Sixteen.
This isn't a minor difference. The gap represents decades of divergent regulatory philosophy, scientific advancement, and consumer protection standards between two regions that otherwise pride themselves on rigorous safety oversight.
The real question isn't which regulator is "right"—it's what that gap means for your skin, and why SOLA is bringing European sunscreen technology to North America.
The FDA's 16 Approved UV Filters
The FDA maintains a short list of "over-the-counter" (OTC) sunscreen active ingredients approved in the United States:
- Avobenzone
- Octinoxate
- Octisalate
- Homosalate
- Oxybenzone
- Padimate O
- Zinc oxide
- Titanium dioxide
- And 8 others with more limited use
This list hasn't significantly expanded since the 1970s. While the FDA has reviewed new filters over the past two decades, the approval process is slow and expensive. New UV filters require full safety dossiers, and the FDA's review bar is exceptionally high—which sounds good in theory but creates an unintended consequence: Americans are locked into legacy UV filter technology.
The EU's 30+ Approved Filters: The Future of UV Protection
The European Union's regulatory framework for cosmetics (EC 1223/2009) maintains a different philosophy: it evaluates UV filters through a collaborative scientific process and updates the approved list regularly as new research emerges and new filters are developed.
The EU-approved list includes all 16 FDA-approved filters plus a generation of newer, advanced filters developed over the past two decades — filters designed for stronger UVA performance, better photostability, lighter skin feel, and lower environmental impact than the legacy American list.
Why does this matter? Many of these newer EU-approved filters offer superior UV protection, broader spectrum coverage, better skin feel, and improved photostability compared to FDA-approved alternatives.
The Next Generation of European UV Filters
Several of the EU's newer-generation filters have been used safely in European sunscreens for more than 15 years. As a category, they offer a set of advantages over the legacy filter list:
- Broad UV spectrum coverage: Strong UVA and UVB protection with excellent photostability.
- Lightweight formulation: Effective at lower concentrations than legacy filters, enabling thinner, less greasy sunscreens.
- Formulation flexibility: Work well in combination with other cosmetic ingredients to deliver elegant finishes without compromising SPF performance.
- Safety profile: Long-standing European use and regulatory approval; no bioaccumulation concerns; strong dermatological safety records.
And yet, none of these newer filters are available to American consumers. The FDA has never approved any of them, and there is no clear indication when — or if — it will.
Why the FDA's Process Is Slow (And Why That Matters)
The FDA's review process for new OTC sunscreen ingredients is rigorous, which sounds protective. In practice, it means:
High Cost of Entry
Companies must fund multi-year safety studies, stability data, and clinical trials—easily costing $5–10 million per filter. Established sunscreen manufacturers have budgets for this. Smaller brands don't. This creates a barrier that limits innovation.
Extended Timeline
A new UV filter application to the FDA can take 10+ years from submission to approval. By contrast, the EU's scientific committees review similar data in 2–3 years. Several next-generation filters have been proven safe in Europe for nearly two decades while the FDA hasn't even scheduled reviews.
Regulatory Bottleneck
The FDA treats sunscreen filters as drugs (not cosmetics), which means any new filter must meet pharmaceutical-level approval standards. This is actually more stringent than many drug approvals. It's excellent for safety, but it's terrible for innovation and consumer choice.
Why European Consumers Get Better Sunscreen
Because the EU updates its approved list as science evolves, European manufacturers can offer:
- Advanced filters with better UVA/UVB balance
- Lighter textures (critical for daily use)
- Longer photostability (protection lasts longer)
- Better compatibility with other skincare ingredients
- Cosmetic elegance without sacrificing efficacy
American consumers are effectively stuck with formulations developed in the 1970s and 1980s. The safety profile is good—but the innovation has stalled.
SOLA's Answer: European Sun Protection, Reimagined
SOLA is launching with an EU-approved, next-generation UV filter system as the cornerstone of our formulas. Our formula delivers the advanced UV protection that Europeans have trusted for nearly two decades — protection that still isn't available in the US market today.
Paired with our waterless, single-dose capsule format, that filter system represents a genuine step change in sun protection — European regulatory excellence combined with capsule-based precision dosing.
When Will the FDA Catch Up?
There is no scheduled timeline for US approval of Europe's next-generation UV filters. The FDA has indicated interest in reviewing new sunscreen ingredients, but with only 16 approved filters after 50 years, the pace is glacial.
What this means for you: if you want access to advanced, next-generation UV filters, you either need to:
- Travel to Europe and purchase European-market sunscreens
- Wait for the FDA to eventually review filters already approved in the EU (realistically: decades)
- Support European brands that make advanced sun protection available outside of domestic channels
The Bottom Line
European sunscreen is better — not because European manufacturers are more skilled (they're equally rigorous), but because European consumers have access to newer, more advanced UV filters that have been scientifically validated and safely used for years or decades.
The regulatory gap between the EU and FDA isn't about safety. Both regions prioritize consumer protection. It's about the pace of innovation. The EU updates its approved list as science evolves. The FDA's process is slow enough that innovation effectively stalls.
SOLA is closing that gap. Our EU-approved formula delivers the kind of advanced sun protection that's been standard in Europe for nearly two decades — finally available to a global audience.